Skip to content

Recovery Improved in Covert Stroke With Exercise

Achieving Brain Benefits in Covert Stroke Through Aerobic Exercise

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02068391
Acronym
RISE-2
Enrollment
39
Registered
2014-02-21
Start date
2015-06-01
Completion date
2018-09-12
Last updated
2018-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Small Vessel Diseases

Keywords

covert stroke, cerebral blood flow, grey matter, attention, executive function, aerobic exercise

Brief summary

Silent ischemic, also known as covert stroke vascular disease (CSVD), contributes to neurological deficits that are caused by damage to small blood vessels in the brain. CSVD occurs six to ten times more often that an acute stroke. It is misleading to think, however, that CSVD is an inevitable part of getting old because people with CSVD are at high risk of developing an acute stroke or dementia. In fact, people with more CSVD lesion volume are more likely to develop day to day problems in planning, decision-making and speed of thinking. Unfortunately, there are no proven therapies designed to address CSVD. We propose to test whether aerobic exercise is an intervention that can combat CSVD because the disease is fundamentally a blood flow problem that may be improved by aerobic exercise. We will recruit CSVD adults with moderate to severe lesion burden and use magnetic resonance imaging (MRI) to study the brain in terms of structure, perfusion and function. Participants will be randomly assigned to either our established aerobic exercise program or a control stretching program. Both groups will take part in lab exercise sessions, which are designed to monitor progress and assess adherence to the program. The duration and intensity of their exercise will increase as participants progress. We will use activity log books, phone calls and extra booster exercise sessions, as needed, to maximize retention and adherence. We aim to show that aerobic exercise increases cerebral blood flow (CBF) in frontal-subcortical grey matter, supports regional tissue growth, and improves cognitive function in CSVD adults with substantial risk of acute stroke and dementia. A positive outcome of this research will provide strong support for additional clinical trials aimed at sustaining cognition and maintaining independent living.

Interventions

The 'Stretching Program' will teach stretching for the upper and lower limbs, and the trunk, as well as breathing exercises for relaxation. Supervised group activities will be performed once per week (45 minutes) and self-directed stretching will be encouraged 4 days per week and monitored by an activity journal. The intensity of stretching and number of stretches will be progressed every 2 weeks. Heart rate and perceived exertion will be monitored. The program will last 6 months.

BEHAVIORALExercise Program

The 'Exercise Program' will prescribe specific aerobic exercise to the participants. Supervised group exercise will be performed once per week (60 minutes) and self-directed exercise will be encouraged 4 days per week and monitored by an activity journal. The initial walking prescription will be set at \ 1.6 km and an intensity equivalent to the anaerobic threshold and/or 60% of peak oxygen uptake. Progressions will be made every 2 weeks, increasing distance to a maximum of 6.4 km and then increasing to a max intensity of 80% of peak oxygen uptake and/or max duration of 60 minutes. Heart rate and perceived exertion will be monitored. The program will last 6 months.

Sponsors

Toronto Rehabilitation Institute
CollaboratorOTHER
Sunnybrook Health Sciences Centre
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
55 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Covert stroke: white matter hyperintensities of presumed vascular origin * Ability to walk for 10 minutes without assistance from another person * Fluent in English * Ability to consent

Exclusion criteria

* Highly fit individuals exercising ≥ 150 minutes per week * Dementia * Multiple Sclerosis * Disabling stroke (ischemic or hemorrhagic) * Major concurrent illness (e.g. chronic obstructive lung disorder, current or metastatic cancer, chronic kidney disease) * Major psychiatric illness (e.g. bipolar, schizophrenia, major depression) * Contraindications to MRI scanning (e.g. claustrophobia, implants, prostheses, metallic fragments) * Contraindications to exercise (participants must have medical clearance to exercise from their attending physician) * Recent change in health status (e.g. hospitalization within past month)

Design outcomes

Primary

MeasureTime frameDescription
Change in cerebral blood flow from baseline to 6 months6 monthsPseudo-continuous arterial spin labeling MRI
Change in brain structure from baseline to 6 months6 monthsCortical and subcortical grey matter density using structural MRI

Secondary

MeasureTime frameDescription
Change in brain activity related to attention and executive control tasks from baseline to 6 months6 monthsBlood oxygenation level dependent MRI

Other

MeasureTime frameDescription
Change in autonomic function from baseline to 6 months6 monthsHeart rate variability
Change in autonomic function from 6 to 12 months12 monthsHeart rate variability
Change in arterial stiffness from baseline to 6 months6 monthsCarotid-femoral pulse wave velocity
Change in arterial stiffness from 6 to 12 months12 monthsCarotid-femoral pulse wave velocity
Change in executive function from baseline to 6 months6 monthsTrail Making Test
Change in executive function from 6 to 12 months12 monthsTrail Making Test
Change in white matter integrity from baseline to 6 months6 monthsDiffusion tensor imaging (DTI) MRI
Change in balance from 6 to 12 months12 monthsSpatial-temporal synchronization of center of pressure
Change in dual task gait from baseline to 6 months6 monthsComparison of normal gait to gait with verbal math challenge
Change in dual task gait from 6 to 12 months12 monthsComparison of normal gait to gait with verbal math challenge
Change in grip strength from baseline to 6 months6 monthsMaximum grip strength with dynamometer
Change in grip strength from 6 to 12 months12 monthsMaximum grip strength with dynamometer
Change in balance from baseline to 6 months6 monthsSpatial-temporal synchronization of center of pressure
Change in aerobic fitness from baseline to 6 months6 monthsPeak oxygen uptake
Change in aerobic fitness from 6 to 12 months12 monthsPeak oxygen uptake

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026